The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-((3-(3-fluoro-4-(4-(4-fluorophenylamino)piperidin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide ID: ALA4553174
PubChem CID: 155510400
Max Phase: Preclinical
Molecular Formula: C23H26F2N4O3
Molecular Weight: 444.48
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)NC[C@H]1CN(c2ccc(N3CCC(Nc4ccc(F)cc4)CC3)c(F)c2)C(=O)O1
Standard InChI: InChI=1S/C23H26F2N4O3/c1-15(30)26-13-20-14-29(23(31)32-20)19-6-7-22(21(25)12-19)28-10-8-18(9-11-28)27-17-4-2-16(24)3-5-17/h2-7,12,18,20,27H,8-11,13-14H2,1H3,(H,26,30)/t20-/m0/s1
Standard InChI Key: JQLHRNUPRKHACL-FQEVSTJZSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
19.8809 -19.4227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8809 -20.2399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5861 -20.6444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2914 -20.2399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2914 -19.4227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5861 -19.0100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1737 -20.6496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1749 -21.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4665 -21.8742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4673 -22.6906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1762 -23.0990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8856 -22.6850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8813 -21.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9967 -19.0183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7035 -19.4307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4119 -19.0248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4147 -18.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7032 -17.7962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9977 -18.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1231 -17.7993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8648 -18.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4126 -17.5263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0051 -16.8179 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2056 -16.9866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5977 -16.4405 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2252 -17.6130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7066 -16.9526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5192 -17.0394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0005 -16.3790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8503 -17.7864 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2901 -17.7957 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.1784 -23.9162 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
2 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
5 14 1 0
17 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
24 25 2 0
22 26 1 1
26 27 1 0
27 28 1 0
28 29 1 0
28 30 2 0
19 31 1 0
11 32 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 444.48Molecular Weight (Monoisotopic): 444.1973AlogP: 3.51#Rotatable Bonds: 6Polar Surface Area: 73.91Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.06CX LogP: 2.28CX LogD: 2.28Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.71Np Likeness Score: -1.64
References 1. Hou Y, Dong Y, Ye T, Jiang J, Ding L, Qin M, Ding X, Zhao Y.. (2019) Synthesis and antibacterial evaluation of novel oxazolidinone derivatives containing a piperidinyl moiety., 29 (23): [PMID:31676225 ] [10.1016/j.bmcl.2019.126746 ]